PPP3CB p.Gly22Arg

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_021132.4(PPP3CB):​c.64G>C​(p.Gly22Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000076 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

PPP3CB
NM_021132.4 missense

Scores

2
3
14

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.86

Publications

0 publications found
Variant links:
Genes affected
PPP3CB (HGNC:9315): (protein phosphatase 3 catalytic subunit beta) Enables several functions, including calmodulin binding activity; calmodulin-dependent protein phosphatase activity; and protein phosphatase 2B binding activity. Involved in calcineurin-NFAT signaling cascade; positive regulation of transcription by RNA polymerase II; and protein dephosphorylation. Located in cytoplasm. Part of calcineurin complex. Implicated in aortic valve stenosis. Biomarker of focal segmental glomerulosclerosis and schizophrenia. [provided by Alliance of Genome Resources, Apr 2022]
PPP3CB-AS1 (HGNC:50750): (PPP3CB antisense RNA 1 (head to head))

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_021132.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22386447).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021132.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPP3CB
NM_021132.4
MANE Select
c.64G>Cp.Gly22Arg
missense
Exon 1 of 14NP_066955.1P16298-1
PPP3CB
NM_001142353.3
c.64G>Cp.Gly22Arg
missense
Exon 1 of 14NP_001135825.1P16298-4
PPP3CB
NM_001142354.3
c.64G>Cp.Gly22Arg
missense
Exon 1 of 13NP_001135826.1P16298-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPP3CB
ENST00000360663.10
TSL:1 MANE Select
c.64G>Cp.Gly22Arg
missense
Exon 1 of 14ENSP00000353881.5P16298-1
PPP3CB
ENST00000394829.6
TSL:1
c.64G>Cp.Gly22Arg
missense
Exon 1 of 14ENSP00000378306.2P16298-4
PPP3CB
ENST00000394828.6
TSL:1
c.64G>Cp.Gly22Arg
missense
Exon 1 of 13ENSP00000378305.2P16298-3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00000761
AC:
6
AN:
788178
Hom.:
0
Cov.:
28
AF XY:
0.00000989
AC XY:
4
AN XY:
404394
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
15244
American (AMR)
AF:
0.00
AC:
0
AN:
28734
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13304
East Asian (EAS)
AF:
0.00
AC:
0
AN:
10984
South Asian (SAS)
AF:
0.00
AC:
0
AN:
70002
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
30044
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3306
European-Non Finnish (NFE)
AF:
0.0000102
AC:
6
AN:
586126
Other (OTH)
AF:
0.00
AC:
0
AN:
30434
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.250
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.46
BayesDel_addAF
Benign
-0.088
T
BayesDel_noAF
Benign
-0.36
CADD
Pathogenic
26
DANN
Uncertain
0.99
DEOGEN2
Benign
0.12
T
Eigen
Benign
-0.26
Eigen_PC
Benign
-0.22
FATHMM_MKL
Benign
0.013
N
LIST_S2
Benign
0.82
T
M_CAP
Pathogenic
0.65
D
MetaRNN
Benign
0.22
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.14
N
PhyloP100
2.9
PrimateAI
Pathogenic
0.94
D
PROVEAN
Benign
-0.070
N
REVEL
Benign
0.038
Sift
Uncertain
0.014
D
Sift4G
Benign
0.58
T
PromoterAI
0.030
Neutral
Varity_R
0.20
gMVP
0.37
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

hg19: chr10-75255584;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.